CORRECTION: Guggenheim Initiated Coverage on the Stock With a Buy Rating and Announced a $32 Price Target on March 13
Guggenheim Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $32
GH Research Analyst Ratings
RBC Capital Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $31
RBC Initiates GH Research at Outperform, Speculative Risk With $31 Price Target
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
CCORF Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35
TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
Promising Trial Results and Strong Financials Justify Buy Rating for GH Research
JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
GH Research Is Maintained at Buy by Stifel
Stifel Maintains GH Research(GHRS.US) With Buy Rating, Announces Target Price $32
GH Research Initiated at Overweight by Cantor Fitzgerald
GH Research Analyst Ratings
Cantor Fitzgerald Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $14
Rodman & Renshaw Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $36
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
Rodman & Renshaw Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $42
JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40